Chinese firm plan to buy Gland Pharma faces CCEA objections Ruby Khatun Khatun4 Aug 2017 9:14 AM ISTNew Delhi: The CCEA has raised objections to the Rs 8,800 crore proposal of Chinese pharma firm Shanghai Fosun to acquire majority stake in domestic...
ITC in search of a CEO for its multi-speciality hospital Ruby Khatun Khatun4 Aug 2017 9:00 AM ISTKolkata: Diversified conglomerate ITC Limited was now in the search of a CEO for its proposed foray into the healthcare sector by way of setting up a...
Nalinikanth Gollagunta appointed as President and CEO of GE Healthcare India, South Asia Ruby Khatun Khatun3 Aug 2017 9:30 AM ISTBangalore: GE Healthcare announced the appointment of Nalinikanth (Nal) Gollagunta as President and CEO, GE Healthcare India and South Asia and...
PlasmaGen raises Rs 160.4 crore from Eight Roads Ventures, F-Prime Ruby Khatun Khatun3 Aug 2017 9:30 AM ISTBengaluru: PlasmaGen BioSciences Private Limited, a city based biopharmaceutical company focused on blood plasma-derived products, announced USD 25...
Lupin Aurangabad plant undergoes USFDA inspection Ruby Khatun Khatun3 Aug 2017 9:21 AM ISTNew Delhi: Drug major Lupin on Monday said the US health regulator has completed the prior approval inspection (PAI) of its Aurangabad manufacturing...
Alembic Pharma gets USFDA go-ahead for anti-bacterial drug Ruby Khatun Khatun3 Aug 2017 9:20 AM ISTNew Delhi: Drug firm Alembic Pharmaceuticals has received the US health regulator's nod for anti-bacterial Doxycycline capsules."The company has...
Glenmark Pharma releases investigational skin findings Ruby Khatun Khatun3 Aug 2017 9:17 AM ISTNew Delhi: Drug major Glenmark Pharmaceuticals on Tuesday came out with positive findings from phase 2 a study of GBR 830, an investigational...
After perfect storm, Dr Reddy's seeks recovery this fiscal Ruby Khatun Khatun3 Aug 2017 9:16 AM ISTNew Delhi: After facing a "perfect storm" of adverse developments, Dr Reddy's Laboratories expects better financial performance this fiscal with cost...
Key drug sales push Pfizer profit up 50 percent Ruby Khatun Khatun3 Aug 2017 9:15 AM ISTRising sales of key drugs, lower one-time charges and reduced manufacturing costs helped drive Pfizer's profit up 50 percent in the second quarter.The...
AstraZeneca a tricky takeover target after big cancer drug blow Ruby Khatun Khatun3 Aug 2017 9:14 AM ISTLONDON: Hurdles ranging from existing commercial tie-ups to politics make drugmaker AstraZeneca a problematic takeover target in the wake of last...
Medical devices to carry MRP on packs from Jan 1, 2018: Govt Ruby Khatun Khatun2 Aug 2017 10:00 AM ISTNew Delhi: Medical devices will have to mandatorily carry maximum retail price (MRP) on packages from January 1, 2018, the government informed...
Cipla eyes filing over 20 ANDAs in US this fiscal Ruby Khatun Khatun2 Aug 2017 9:25 AM ISTNew Delhi: Drug major Cipla has said it is looking to file more than 20 applications seeking approval for its generic medicines from the US health...
